Dextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by Catalent Pharma Solutions for CorePharma, LLC Middlesex, NJ 08846 NDC 64720-327-09
Published March 6, 2013 · Recall initiated: December 4, 2012
Summary
FDA records drug Class II recall D-171-2013, published March 6, 2013 and initiated December 4, 2012. Recalling firm: Amedra Pharmaceuticals LLC; Status: Terminated; Reported quantity: 1,176 bottles; Lot: Lot 238316, exp 01/31/2014. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Amedra Pharmaceuticals LLC
- Distributor
- Nationwide and Puerto Rico.
- Lot
- Lot 238316, exp 01/31/2014
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADexedrine® (Dextroamphetamine Sulfate) Spansules® Sustained Release Capsules 15mg, 90 count bottle, Rx only,January 1, 2014
- FDADextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by CatalentMarch 6, 2013
- FDADextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by CatalentMarch 6, 2013
- FDABelladonna Alkaloids (hyoscyamine sulfate, USP 0.1037 mg; atropine sulfate, USP 0.0194 mg; scopolamine HBr,March 6, 2013
- FDAFurosemide Injection USP (10 mg/mL), 4 mL in 5 mL Fliptop Vial, Rx only, Hospira Inc., Lake Forest, IL --- NDCMarch 6, 2013
- FDAEXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials,March 6, 2013
Questions about this recall
Was Dextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by Catalent Pharma Solutions for CorePharma, LLC Middlesex, NJ 08846 NDC 64720-327-09 recalled?
Yes. FDA published recall D-171-2013 on March 6, 2013. Reported hazard: Failed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.
What should I do if I have this product?
Voluntary: Firm initiated · Letter